US20020058977A1 - High tensile strength bioelectric cable - Google Patents
High tensile strength bioelectric cable Download PDFInfo
- Publication number
- US20020058977A1 US20020058977A1 US10/037,919 US3791902A US2002058977A1 US 20020058977 A1 US20020058977 A1 US 20020058977A1 US 3791902 A US3791902 A US 3791902A US 2002058977 A1 US2002058977 A1 US 2002058977A1
- Authority
- US
- United States
- Prior art keywords
- cable
- tensile strength
- leads
- conductor
- insulator portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
Definitions
- the present invention is a bioelectrical stimulus cable that is more biocompatible and has a greater number of leads than currently available bioelectrical stimulus cables.
- Bioelectrical stimulus implant cables include cardiac implant cables, neuro-stimulus cables and any cable designed to apply an electric charge to body tissue or to supply a device which applies such a charge.
- Bioelectrical stimulus cables must meet a number of challenging criteria.
- a cardiac implant cable typically stretches from a subcutaneous fat deposit through the rib cage to a cardiac implant such as a pacemaker.
- the cable is continuously perturbed by the beating of the heart. It must not, however, become fatigued by this constant flexure to the point where a substantial number of the cable fibrils break.
- a fibril is a thin wire used in a cable.
- a bioelectrical stimulus cable must also be completely biocompatible. That is, the exterior of the cable must be made of biocompatible materials and the constant flexure caused by movement of the patient or his organs must not cause a rupture that would lead to the release of materials that are not biocompatible.
- the present invention is a high tensile strength bioelectrical cable comprising a conductor-insulator portion including conductive wires set into an insulating medium.
- a braided sheath encompasses the conductor-insulator portion and defines an inner diameter, which shrinks when the cable is pulled longitudinally, thereby squeezing the conductor-insulator portion and increasing the tensile strength of the cable.
- FIG. 1 is a greatly expanded transverse cross-sectional view of a bioelectrical stimulus cable according to the present invention.
- FIG. 2 is a greatly expanded longitudinal cutaway view of the bioelectrical stimulus cable of FIG. 1.
- FIG. 3 is a still more greatly expanded cross-sectional view of a single insulated lead of the bioelectrical stimulus cable of FIG. 1.
- FIG. 4 is a greatly expanded transverse cross-sectional view of an alternative preferred embodiment of a bioelectrical stimulus cable according to the present invention.
- FIG. 5 is a greatly expanded longitudinal cutaway view of the bioelectrical stimulus cable of FIG. 3
- FIG. 6 is a still more greatly expanded cross-sectional view of a single coaxial lead of the bioelectrical stimulus cable of FIG. 4.
- FIG. 7 is a still more greatly expanded cross-sectional view of a single insulated lead of a bioelectrical stimulus cable identical with that of FIG. 1 except that it includes the insulated leads shown in FIG. 7.
- FIG. 8 is a greatly expanded transverse cross-sectional view of a cable for treating congestive heart failure.
- FIG. 9 is a greatly expanded longitudinal cutaway view of the cable of FIG. 8.
- a preferred embodiment of a bioelectrical stimulus cable 10 has a diameter of 3 mm (119 mils).
- a central lumen 12 preferably made of polyurethane or silicone and having an inner diameter of 0.45 mm (0.018′′) and an outer diameter of 0.96 mm (0.038′′).
- the central lumen 12 performs at least two important functions. First, it may accommodate a guide wire during the insertion process. Second, it adds rigidity to the cable.
- central lumen 12 Arranged about central lumen 12 are thirteen insulated leads 20 , each having a diameter of 0.22 mm (0.0087′′). In an alternative embodiment fillers, each also having a diameter of 0.22 mm (0.0087′′), are interspersed with a reduced number of leads 20 . Referring to FIG. 2, the leads 20 are wrapped about central lumen 12 in a “lazy” helix having a lay length of between 10 mm (0.4′′) and 15 mm (0.6′′). Such an arrangement is necessary when so many leads are used, thirteen leads being considerably more than is typically available in prior art cables.
- FIGS. 4, 5 and 6 show an alternative embodiment 29 having a central filler 12 ′ rather than tube 12 and twenty coaxial insulated leads 30 twisted counter to leads 20 .
- Each coaxial lead 30 has a central conductor 32 that is 40 ⁇ m in diameter and is made from four 20 ⁇ m (0.8 mil) strands of silver plated CS95, available from Phelps Dodge of Inman, S.C., that have been stranded and twisted together.
- Central conductor 32 is covered with a 38 ⁇ m (1.5 mil) thick coating 36 of fluorinated ethylene propylene (FEP). This, in turn, is covered with a shield 38 made of 20 ⁇ m (0.8 mil) strands of CS95 that collectively provide 90% minimum coverage.
- FEP fluorinated ethylene propylene
- the provision of coaxial leads 30 permits a far greater total bandwidth for the transmission of instrumentation data than is currently available in bioelectrical stimulus leads.
- each of the insulated leads 20 includes seven strands or fibrils 22 , each of which is a 40 ⁇ m (1.57 mil) strand of MP35N, an alloy that is frequently used in cardiac cables due to its durability and biocompatibility.
- MP35N is widely available from several different suppliers.
- one of the fibrils 22 is a drawn filled tube (DFT) with walls of MP35N filled with silver.
- a bimaterial coat 24 Immediately surrounding each group of fibrils 22 is a bimaterial coat 24 , having an interior coating 26 that is 25.4 ⁇ m (1 mil) thick and is made of ethylene tetrafluoroethylene (ETFE).
- ETFE ethylene tetrafluoroethylene
- An outer elastomeric coating 28 of coat 24 is 25.4 ⁇ m (1 mil) thick and may be made of polyurethane. Because ETFE has a higher melting temperature than polyurethane, ETFE interior coating 26 may be coated with melted polyurethane, without melting any of the ETFE.
- an alternative preferred embodiment includes leads 20 ′, in place of leads 20 .
- Each lead 20 ′ is made of seven strands 21 ′ of 12.7 ⁇ m (0.5 mil) thick fibrils 23 of MP35N.
- Lead 20 ′ is even more resilient and wear resistant than lead 20 .
- the use of the smaller diameter fibrils imparts superior physical characteristics to cable 20 ′ due to the inherently greater flexibility and freedom from inclusions of these fibrils 23 .
- Coat 24 is an important part of the present invention.
- the principal problem that should be avoided in cardiac cables is that of fibrils 22 breaking from extended fatigue.
- the breaking of a fibril does not typically occur in a single undifferentiated step. Rather, the fibril first develops a sharp bend or kink through extended wear. After the kink is formed a break typically occurs fairly rapidly. If a fibril does not kink it is far less likely to ever break.
- ETFE is a rigid material that holds the fibrils so that they remain straight and unbent. ETFE is also a low friction material, so that each set of fibrils 22 may slide with respect to the interior surface of coating 26 , thereby avoiding internal strain.
- Elastomeric coating 28 provides cushioning between neighboring leads 20 and helps to prevent fibril kinking and fatigue by absorbing the shock caused by the heart beats.
- Wall 50 is elastomeric or spongy enough to dampen the vibrations caused by the beating of the heart yet thick and substantial enough to help prevent kinking of the fibrils 22 .
- Outside of wall 50 is a 100 ⁇ m (0.004′′) tubular polyester fiber braid 52 . This braid imparts tensile strength to cable 10 not only because of its own tensile strength but also because when it is pulled it contracts radially, squeezing the interior portions of cable 10 and thereby increasing the overall tensile strength of cable 10 .
- a 127 ⁇ m (0.005′′) polyurethane or silicone wall 60 is a 127 ⁇ m (0.005′′) polyurethane or silicone wall 60 .
- this wall is made of polyurethane with TFE end groups, to create a low friction surface.
- a low friction surface 64 may be helpful when removing cable 10 from a patient as is sometimes necessary.
- the surface 64 may be ribbed or otherwise textured with a 10 micron order of magnitude three dimensional structure designed to encourage healthy tissue growth about the cable and to prevent the growth of scar tissue. Interlinked holes within the range of 2-150 microns in diameter have been found to be an effective structure for encouraging the growth of healthy tissue.
- surface 64 is textured with interlinked holes in this size range.
- the radially outermost portion of cable 10 is separable from the portion containing the leads 20 , so that the lead containing portion may be replaced without removing surface 64 which may be retained by body tissue.
- a bioelectrical stimulus cable 110 designed for the treatment of congestive heart failure includes eight insulated leads 20 ′ (shown in greater detail in FIG. 7), each of which can be used either for the transmission of power or for the transmission of sensor data or control data.
- leads 20 ′ shown in greater detail in FIG. 7
- the presence of eight leads, each of which could be used for power transmission in cable 110 permits flexibility in meeting these requirements.
- Leads 20 ′ are wound helically about a central silicone rod 112 that has a diameter of 333 ⁇ m (13 mils).
- a tube of silicone Surrounding leads 20 ′ is a tube of silicone having a wall thickness of 0.33 mm (13 mils). Exterior to this tube is another tube 116 having a wall thickness of 127 ⁇ m (5 mils) being made of 80% polyurethane and 20% silicone.
- the entire cable 110 has a diameter of 1.651 mm (65 mils) as opposed to 3 mm for cable 10 . This reduced diameter is desirable in a cable for the treatment of congestive heart failure.
Abstract
A high tensile strength bioelectrical stimulus cable comprising a conductor-insulator portion including conductive wires set into an insulating medium and a braided sheath encompassing the conductor-insulator portion and defining an inner diameter, the inner diameter shrinking when the cable is pulled longitudinally, thereby squeezing the conductor-insulator portion and increasing the tensile strength of the cable.
Description
- The present application is a divisional of U.S. patent application Ser. No. 09/415,534, filed Oct. 8, 1999.
- The present invention is a bioelectrical stimulus cable that is more biocompatible and has a greater number of leads than currently available bioelectrical stimulus cables.
- Bioelectrical stimulus implant cables include cardiac implant cables, neuro-stimulus cables and any cable designed to apply an electric charge to body tissue or to supply a device which applies such a charge.
- Bioelectrical stimulus cables must meet a number of challenging criteria. For example, a cardiac implant cable typically stretches from a subcutaneous fat deposit through the rib cage to a cardiac implant such as a pacemaker. The cable is continuously perturbed by the beating of the heart. It must not, however, become fatigued by this constant flexure to the point where a substantial number of the cable fibrils break. (A fibril is a thin wire used in a cable.) Not only does a broken fibril not conduct electricity to the implant but it also may work its way through the insulating layers of the cable and make harmful contact with body tissue. A bioelectrical stimulus cable must also be completely biocompatible. That is, the exterior of the cable must be made of biocompatible materials and the constant flexure caused by movement of the patient or his organs must not cause a rupture that would lead to the release of materials that are not biocompatible.
- Heretofore, the general approach to the production of this type of cable has been to produce a tight helix so each fibril would experience only a small part of the total cable flexure. One problem with a tight helix is that it places a restriction on the number of independent leads that can be included in the cable. If more leads could be included in a cable, however, more purposes could be served with respect to an implant. For example, a single cardiac implant may function as both a pacemaker and as a defibrillator and may require a set of leads to power the pacemaker and a separate set of leads to power the defibrillator when it is needed. Additionally, a set of control leads may be necessary to, for example, adjust the operation of the pacemaker and the defibrillator.
- Another problem encountered in the use of bioelectrical stimulus cables is the formation of scar tissue about the cable. It is occasionally necessary to replace a bioelectrical stimulus cable. Removing the old cable can provide a difficult challenge to the surgeon performing the replacement if considerable scar tissue has grown about and adhered itself to the cable, as is typical.
- The present invention is a high tensile strength bioelectrical cable comprising a conductor-insulator portion including conductive wires set into an insulating medium. A braided sheath encompasses the conductor-insulator portion and defines an inner diameter, which shrinks when the cable is pulled longitudinally, thereby squeezing the conductor-insulator portion and increasing the tensile strength of the cable.
- The foregoing and other objectives, features, and advantages of the invention will be more readily understood upon consideration of the following detailed description of the invention, taken in conjunction with the accompanying drawings.
- FIG. 1 is a greatly expanded transverse cross-sectional view of a bioelectrical stimulus cable according to the present invention.
- FIG. 2 is a greatly expanded longitudinal cutaway view of the bioelectrical stimulus cable of FIG. 1.
- FIG. 3 is a still more greatly expanded cross-sectional view of a single insulated lead of the bioelectrical stimulus cable of FIG. 1.
- FIG. 4 is a greatly expanded transverse cross-sectional view of an alternative preferred embodiment of a bioelectrical stimulus cable according to the present invention.
- FIG. 5 is a greatly expanded longitudinal cutaway view of the bioelectrical stimulus cable of FIG. 3
- FIG. 6 is a still more greatly expanded cross-sectional view of a single coaxial lead of the bioelectrical stimulus cable of FIG. 4.
- FIG. 7 is a still more greatly expanded cross-sectional view of a single insulated lead of a bioelectrical stimulus cable identical with that of FIG. 1 except that it includes the insulated leads shown in FIG. 7.
- FIG. 8 is a greatly expanded transverse cross-sectional view of a cable for treating congestive heart failure.
- FIG. 9 is a greatly expanded longitudinal cutaway view of the cable of FIG. 8.
- Referring to FIGS. 1 and 2, a preferred embodiment of a
bioelectrical stimulus cable 10 according to the present invention has a diameter of 3 mm (119 mils). At its center is acentral lumen 12 preferably made of polyurethane or silicone and having an inner diameter of 0.45 mm (0.018″) and an outer diameter of 0.96 mm (0.038″). Thecentral lumen 12 performs at least two important functions. First, it may accommodate a guide wire during the insertion process. Second, it adds rigidity to the cable. - Arranged about
central lumen 12 are thirteen insulatedleads 20, each having a diameter of 0.22 mm (0.0087″). In an alternative embodiment fillers, each also having a diameter of 0.22 mm (0.0087″), are interspersed with a reduced number ofleads 20. Referring to FIG. 2, theleads 20 are wrapped aboutcentral lumen 12 in a “lazy” helix having a lay length of between 10 mm (0.4″) and 15 mm (0.6″). Such an arrangement is necessary when so many leads are used, thirteen leads being considerably more than is typically available in prior art cables. - FIGS. 4, 5 and6 show an
alternative embodiment 29 having acentral filler 12′ rather thantube 12 and twenty coaxial insulated leads 30 twisted counter to leads 20. Eachcoaxial lead 30 has acentral conductor 32 that is 40 μm in diameter and is made from four 20 μm (0.8 mil) strands of silver plated CS95, available from Phelps Dodge of Inman, S.C., that have been stranded and twisted together.Central conductor 32 is covered with a 38 μm (1.5 mil)thick coating 36 of fluorinated ethylene propylene (FEP). This, in turn, is covered with ashield 38 made of 20 μm (0.8 mil) strands of CS95 that collectively provide 90% minimum coverage. A 13 μm (0.5 mil)wall 39 of polyurethane surround thecoaxial lead 30, which has a 50 ohm impedance. The provision of coaxial leads 30 permits a far greater total bandwidth for the transmission of instrumentation data than is currently available in bioelectrical stimulus leads. - Referring to FIG. 3, each of the
insulated leads 20, includes seven strands orfibrils 22, each of which is a 40 μm (1.57 mil) strand of MP35N, an alloy that is frequently used in cardiac cables due to its durability and biocompatibility. MP35N is widely available from several different suppliers. Alternatively, one of thefibrils 22 is a drawn filled tube (DFT) with walls of MP35N filled with silver. Immediately surrounding each group offibrils 22 is abimaterial coat 24, having aninterior coating 26 that is 25.4 μm (1 mil) thick and is made of ethylene tetrafluoroethylene (ETFE). An outerelastomeric coating 28 ofcoat 24 is 25.4 μm (1 mil) thick and may be made of polyurethane. Because ETFE has a higher melting temperature than polyurethane, ETFEinterior coating 26 may be coated with melted polyurethane, without melting any of the ETFE. - Referring to FIG. 7, an alternative preferred embodiment includes
leads 20′, in place ofleads 20. Eachlead 20′ is made of seven strands 21′ of 12.7 μm (0.5 mil)thick fibrils 23 of MP35N.Lead 20′ is even more resilient and wear resistant thanlead 20. The use of the smaller diameter fibrils imparts superior physical characteristics tocable 20′ due to the inherently greater flexibility and freedom from inclusions of thesefibrils 23. -
Coat 24 is an important part of the present invention. The principal problem that should be avoided in cardiac cables is that offibrils 22 breaking from extended fatigue. The breaking of a fibril, however, does not typically occur in a single undifferentiated step. Rather, the fibril first develops a sharp bend or kink through extended wear. After the kink is formed a break typically occurs fairly rapidly. If a fibril does not kink it is far less likely to ever break. ETFE is a rigid material that holds the fibrils so that they remain straight and unbent. ETFE is also a low friction material, so that each set offibrils 22 may slide with respect to the interior surface ofcoating 26, thereby avoiding internal strain.Elastomeric coating 28 provides cushioning between neighboring leads 20 and helps to prevent fibril kinking and fatigue by absorbing the shock caused by the heart beats. - Surrounding insulated leads20 is a 500 μm (0.02″)
tubular wall 50 of elastomeric insulating material, such as silicone or polyurethane.Wall 50 is elastomeric or spongy enough to dampen the vibrations caused by the beating of the heart yet thick and substantial enough to help prevent kinking of thefibrils 22. Outside ofwall 50 is a 100 μm (0.004″) tubularpolyester fiber braid 52. This braid imparts tensile strength tocable 10 not only because of its own tensile strength but also because when it is pulled it contracts radially, squeezing the interior portions ofcable 10 and thereby increasing the overall tensile strength ofcable 10. - Finally, at the radial exterior of
cable 10 is a 127 μm (0.005″) polyurethane orsilicone wall 60. Preferably, this wall is made of polyurethane with TFE end groups, to create a low friction surface. Alow friction surface 64 may be helpful when removingcable 10 from a patient as is sometimes necessary. In addition, thesurface 64 may be ribbed or otherwise textured with a 10 micron order of magnitude three dimensional structure designed to encourage healthy tissue growth about the cable and to prevent the growth of scar tissue. Interlinked holes within the range of 2-150 microns in diameter have been found to be an effective structure for encouraging the growth of healthy tissue. In onepreferred embodiment surface 64 is textured with interlinked holes in this size range. In an additional preferred embodiment the radially outermost portion ofcable 10 is separable from the portion containing theleads 20, so that the lead containing portion may be replaced without removingsurface 64 which may be retained by body tissue. - Referring to FIGS. 8 and 9 a
bioelectrical stimulus cable 110 designed for the treatment of congestive heart failure includes eightinsulated leads 20′ (shown in greater detail in FIG. 7), each of which can be used either for the transmission of power or for the transmission of sensor data or control data. In the treatment of congestive heart failure it is typically desirable to stimulate the heart at a number of different sites. The presence of eight leads, each of which could be used for power transmission incable 110, permits flexibility in meeting these requirements. - Leads20′ are wound helically about a
central silicone rod 112 that has a diameter of 333 μm (13 mils). Surrounding leads 20′ is a tube of silicone having a wall thickness of 0.33 mm (13 mils). Exterior to this tube is anothertube 116 having a wall thickness of 127 μm (5 mils) being made of 80% polyurethane and 20% silicone. Theentire cable 110 has a diameter of 1.651 mm (65 mils) as opposed to 3 mm forcable 10. This reduced diameter is desirable in a cable for the treatment of congestive heart failure. - The terms and expressions which have been employed in the foregoing specification are used therein as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding equivalents of the features shown and described or portions thereof, it being recognized that the scope of the invention is defined and limited only by the claims which follow.
Claims (2)
1. A high tensile strength bioelectrical stimulus cable comprising:
(a) a conductor-insulator portion including conductive wires set into an insulating medium; and
(b) a braided sheath encompassing said conductor-insulator portion and defining an inner diameter, said inner diameter shrinking when said cable is pulled longitudinally, thereby squeezing said conductor-insulator portion and increasing the tensile strength of said cable.
2. The cable of claim 1 wherein said braided sheath is braided from polyester fiber.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/037,919 US20020058977A1 (en) | 1999-10-08 | 2002-01-02 | High tensile strength bioelectric cable |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/415,534 US6374141B1 (en) | 1999-10-08 | 1999-10-08 | Multi-lead bioelectrical stimulus cable |
US10/037,919 US20020058977A1 (en) | 1999-10-08 | 2002-01-02 | High tensile strength bioelectric cable |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/415,534 Division US6374141B1 (en) | 1999-10-08 | 1999-10-08 | Multi-lead bioelectrical stimulus cable |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020058977A1 true US20020058977A1 (en) | 2002-05-16 |
Family
ID=23646087
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/415,534 Expired - Lifetime US6374141B1 (en) | 1999-10-08 | 1999-10-08 | Multi-lead bioelectrical stimulus cable |
US10/037,919 Abandoned US20020058977A1 (en) | 1999-10-08 | 2002-01-02 | High tensile strength bioelectric cable |
US10/038,965 Abandoned US20020058979A1 (en) | 1999-10-08 | 2002-01-03 | Biolectrical cable having a textured outer surface |
US10/039,134 Abandoned US20020058980A1 (en) | 1999-10-08 | 2002-01-03 | Biolelectrical cable having a low friction outer surface |
US10/038,560 Expired - Lifetime US6792316B2 (en) | 1999-10-08 | 2002-01-03 | Cardiac implant cable having a coaxial lead |
US10/043,972 Abandoned US20020068965A1 (en) | 1999-10-08 | 2002-01-11 | Biolectrical cable having wires wrapped in a lazy helix |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/415,534 Expired - Lifetime US6374141B1 (en) | 1999-10-08 | 1999-10-08 | Multi-lead bioelectrical stimulus cable |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/038,965 Abandoned US20020058979A1 (en) | 1999-10-08 | 2002-01-03 | Biolectrical cable having a textured outer surface |
US10/039,134 Abandoned US20020058980A1 (en) | 1999-10-08 | 2002-01-03 | Biolelectrical cable having a low friction outer surface |
US10/038,560 Expired - Lifetime US6792316B2 (en) | 1999-10-08 | 2002-01-03 | Cardiac implant cable having a coaxial lead |
US10/043,972 Abandoned US20020068965A1 (en) | 1999-10-08 | 2002-01-11 | Biolectrical cable having wires wrapped in a lazy helix |
Country Status (1)
Country | Link |
---|---|
US (6) | US6374141B1 (en) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0108088D0 (en) | 2001-03-30 | 2001-05-23 | Browning Healthcare Ltd | Surgical implant |
US20030105505A1 (en) * | 2001-12-05 | 2003-06-05 | Pianca Anne M. | Medical leads with superior handling characteristics |
US7904178B2 (en) * | 2002-04-11 | 2011-03-08 | Medtronic, Inc. | Medical electrical lead body designs incorporating energy dissipating shunt |
US8396568B2 (en) * | 2002-04-11 | 2013-03-12 | Medtronic, Inc. | Medical electrical lead body designs incorporating energy dissipating shunt |
US20030216800A1 (en) * | 2002-04-11 | 2003-11-20 | Medtronic, Inc. | Implantable medical device conductor insulation and process for forming |
US7783365B2 (en) * | 2002-04-11 | 2010-08-24 | Medtronic, Inc. | Implantable medical device conductor insulation and process for forming |
ITFI20020145A1 (en) * | 2002-08-01 | 2004-02-02 | Giulio Nicita | DEVICE FOR THE SURGICAL TREATMENT OF FEMALE PROLAXIS. |
US8103358B2 (en) * | 2003-04-04 | 2012-01-24 | Medtronic, Inc. | Mapping guidelet |
US20040215299A1 (en) * | 2003-04-23 | 2004-10-28 | Medtronic, Inc. | Implantable medical device conductor insulation and process for forming |
US7138582B2 (en) * | 2003-06-24 | 2006-11-21 | Medtronic, Inc. | Medical electrical lead conductor formed from modified MP35N alloy |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US6843870B1 (en) | 2003-07-22 | 2005-01-18 | Epic Biosonics Inc. | Implantable electrical cable and method of making |
US8048369B2 (en) * | 2003-09-05 | 2011-11-01 | Ati Properties, Inc. | Cobalt-nickel-chromium-molybdenum alloys with reduced level of titanium nitride inclusions |
EP1680180B1 (en) * | 2003-10-02 | 2007-02-28 | Medtronic, Inc. | Implantable medical lead and method of manufacture |
US7287115B2 (en) * | 2003-10-30 | 2007-10-23 | Kabushiki Kaisha Toshiba | Multi-chip package type memory system |
JP4839224B2 (en) * | 2004-02-04 | 2011-12-21 | ソラテック コーポレーション | Transcutaneous lead parts |
US9155877B2 (en) | 2004-03-30 | 2015-10-13 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7844343B2 (en) | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable medical device |
US7877150B2 (en) | 2004-03-30 | 2011-01-25 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7844344B2 (en) * | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable lead |
US8989840B2 (en) | 2004-03-30 | 2015-03-24 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7309324B2 (en) * | 2004-10-15 | 2007-12-18 | Futuremed Interventional, Inc. | Non-compliant medical balloon having an integral woven fabric layer |
US8280526B2 (en) | 2005-02-01 | 2012-10-02 | Medtronic, Inc. | Extensible implantable medical lead |
US7853332B2 (en) | 2005-04-29 | 2010-12-14 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US8027736B2 (en) * | 2005-04-29 | 2011-09-27 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US9422622B2 (en) | 2006-01-30 | 2016-08-23 | Surfatek Llc | Flexible conductive single wire |
US20100057179A1 (en) * | 2006-01-30 | 2010-03-04 | Chameleon Scientific Corporation | Conductive metal thin coatings for implantable medical sensing devices |
US8180462B2 (en) | 2006-04-18 | 2012-05-15 | Cyberonics, Inc. | Heat dissipation for a lead assembly |
US8478420B2 (en) | 2006-07-12 | 2013-07-02 | Cyberonics, Inc. | Implantable medical device charge balance assessment |
US20080027524A1 (en) | 2006-07-26 | 2008-01-31 | Maschino Steven E | Multi-electrode assembly for an implantable medical device |
US8068920B2 (en) * | 2006-10-03 | 2011-11-29 | Vincent A Gaudiani | Transcoronary sinus pacing system, LV summit pacing, early mitral closure pacing, and methods therefor |
US7974707B2 (en) | 2007-01-26 | 2011-07-05 | Cyberonics, Inc. | Electrode assembly with fibers for a medical device |
US10537730B2 (en) | 2007-02-14 | 2020-01-21 | Medtronic, Inc. | Continuous conductive materials for electromagnetic shielding |
US9044593B2 (en) | 2007-02-14 | 2015-06-02 | Medtronic, Inc. | Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding |
WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
US8483842B2 (en) | 2007-04-25 | 2013-07-09 | Medtronic, Inc. | Lead or lead extension having a conductive body and conductive body contact |
US8942798B2 (en) | 2007-10-26 | 2015-01-27 | Cyberonics, Inc. | Alternative operation mode for an implantable medical device based upon lead condition |
US8868203B2 (en) | 2007-10-26 | 2014-10-21 | Cyberonics, Inc. | Dynamic lead condition detection for an implantable medical device |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US9037263B2 (en) | 2008-03-12 | 2015-05-19 | Medtronic, Inc. | System and method for implantable medical device lead shielding |
US9242100B2 (en) | 2012-08-07 | 2016-01-26 | Nuax, Inc. | Optical fiber-fine wire lead for electrostimulation and sensing |
US8692117B2 (en) * | 2008-05-28 | 2014-04-08 | Cardia Access, Inc. | Durable fine wire electrical conductor suitable for extreme environment applications |
US9513443B2 (en) | 2008-05-28 | 2016-12-06 | John Lawrence Erb | Optical fiber-fine wire conductor and connectors |
US9193313B2 (en) | 2012-03-22 | 2015-11-24 | Nuax, Inc. | Methods and apparatuses involving flexible cable/guidewire/interconnects |
US9025598B1 (en) | 2012-03-22 | 2015-05-05 | Nuax, Inc. | Cable/guidewire/interconnects communication apparatus and methods |
US20100012347A1 (en) * | 2008-07-16 | 2010-01-21 | Greatbatch Ltd. | Blended coiled cable |
US8996134B2 (en) * | 2008-11-07 | 2015-03-31 | W. L. Gore & Associates, Inc. | Implantable lead |
US8364281B2 (en) * | 2008-11-07 | 2013-01-29 | W. L. Gore & Associates, Inc. | Implantable lead |
US20110004286A1 (en) * | 2009-01-02 | 2011-01-06 | Medtronic, Inc. | System and method for cardiac lead |
US9833616B2 (en) * | 2009-01-02 | 2017-12-05 | Medtronic, Inc. | System and method for cardiac lead |
US8864744B2 (en) | 2009-02-25 | 2014-10-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device having laminate-coated braid assembly |
WO2010126887A1 (en) | 2009-04-30 | 2010-11-04 | Medtronic, Inc. | Termination of a shield within an implantable medical lead |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20110112614A1 (en) * | 2009-11-12 | 2011-05-12 | Joshua Haarer | Fiber reinforced silicone for cardiac and neurostimulation leads |
AU2011224383B2 (en) | 2010-03-09 | 2014-01-30 | Heraeus Medical Components Llc | Electrically conductive and mechanically supportive materials for biomedical leads |
US8478428B2 (en) | 2010-04-23 | 2013-07-02 | Cyberonics, Inc. | Helical electrode for nerve stimulation |
US9245668B1 (en) * | 2011-06-29 | 2016-01-26 | Cercacor Laboratories, Inc. | Low noise cable providing communication between electronic sensor components and patient monitor |
US8870860B2 (en) | 2011-08-09 | 2014-10-28 | Covidien Lp | Microwave antenna having a coaxial cable with an adjustable outer conductor configuration |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
EP2838609B1 (en) | 2012-04-19 | 2019-03-06 | Medtronic, Inc. | Paired medical lead bodies with braided conductive shields having different physical parameter values |
EP2885049B1 (en) | 2012-08-14 | 2017-03-08 | Cardiac Pacemakers, Inc. | Lead with an inner conductor provided with a textured insulative layer |
US9295808B2 (en) | 2012-08-14 | 2016-03-29 | Cardiac Pacemakers, Inc. | Medical device with textured surface |
US9031671B2 (en) | 2012-09-21 | 2015-05-12 | Composite Materials Technology, Inc. | Medical implantable lead and manufacture thereof |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US9993638B2 (en) | 2013-12-14 | 2018-06-12 | Medtronic, Inc. | Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9498316B1 (en) | 2014-07-10 | 2016-11-22 | Composite Materials Technology, Inc. | Biocompatible extremely fine tantalum filament scaffolding for bone and soft tissue prosthesis |
US9155605B1 (en) | 2014-07-10 | 2015-10-13 | Composite Materials Technology, Inc. | Biocompatible extremely fine tantalum filament scaffolding for bone and soft tissue prosthesis |
EP3171931B1 (en) | 2014-07-23 | 2021-11-10 | Medtronic, Inc. | Methods of shielding implantable medical leads and implantable medical lead extensions |
EP3191175B1 (en) | 2014-07-24 | 2022-03-02 | Medtronic, Inc. | Apparatus for shielding implantable medical leads and lead extensions |
WO2018031943A1 (en) | 2016-08-12 | 2018-02-15 | Composite Materials Technology, Inc. | Electrolytic capacitor and method for improved electrolytic capacitor anodes |
EP3507242B1 (en) | 2016-09-01 | 2021-07-14 | COMPOSITE MATERIALS TECHNOLOGY, Inc. | Nano-scale/nanostructured si coating on valve metal substrate for lib anodes |
JP6911334B2 (en) * | 2016-11-25 | 2021-07-28 | 日立金属株式会社 | Composite cable |
TWI636770B (en) * | 2017-06-06 | 2018-10-01 | 美商宇心生醫股份有限公司 | Electrocardiogram cable and electrode module |
US11577075B1 (en) | 2018-10-12 | 2023-02-14 | Vincent A. Gaudiani | Transcoronary sinus pacing of his bundle |
US11648397B1 (en) | 2018-10-12 | 2023-05-16 | Vincent Gaudiani | Transcoronary sinus pacing of posteroseptal left ventricular base |
JP6939757B2 (en) * | 2018-11-26 | 2021-09-22 | 日立金属株式会社 | Composite cable |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4484586A (en) * | 1982-05-27 | 1984-11-27 | Berkley & Company, Inc. | Hollow conductive medical tubing |
EP0293499B1 (en) * | 1987-06-01 | 1993-09-01 | Siemens-Elema AB | Implantable multi-pole coaxial lead |
EP0312495A3 (en) * | 1987-10-16 | 1989-08-30 | Institut Straumann Ag | Electrical cable for carrying out at least one stimulation and/or measurement in a human or animal body |
US5358516A (en) * | 1992-12-11 | 1994-10-25 | W. L. Gore & Associates, Inc. | Implantable electrophysiology lead and method of making |
NL9300670A (en) * | 1993-04-20 | 1994-11-16 | Cordis Europ | Catheter with electrically conductive wire reinforcement. |
WO1995001751A1 (en) * | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5845396A (en) * | 1996-12-17 | 1998-12-08 | Pacesetter, Inc. | Co-radial, multi-polar coiled cable lead and method for making the same |
SE9701719D0 (en) * | 1997-05-07 | 1997-05-07 | Pacesetter Ab | Helical winding |
US6400992B1 (en) * | 1999-03-18 | 2002-06-04 | Medtronic, Inc. | Co-extruded, multi-lumen medical lead |
-
1999
- 1999-10-08 US US09/415,534 patent/US6374141B1/en not_active Expired - Lifetime
-
2002
- 2002-01-02 US US10/037,919 patent/US20020058977A1/en not_active Abandoned
- 2002-01-03 US US10/038,965 patent/US20020058979A1/en not_active Abandoned
- 2002-01-03 US US10/039,134 patent/US20020058980A1/en not_active Abandoned
- 2002-01-03 US US10/038,560 patent/US6792316B2/en not_active Expired - Lifetime
- 2002-01-11 US US10/043,972 patent/US20020068965A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020058980A1 (en) | 2002-05-16 |
US20020058979A1 (en) | 2002-05-16 |
US6374141B1 (en) | 2002-04-16 |
US20020068965A1 (en) | 2002-06-06 |
US6792316B2 (en) | 2004-09-14 |
US20020058978A1 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6374141B1 (en) | Multi-lead bioelectrical stimulus cable | |
US4840186A (en) | Implantable multi-pole coaxial lead | |
US4964414A (en) | Electrode for use in implanting in a living body | |
US5330520A (en) | Implantable electrode and sensor lead apparatus | |
US5483022A (en) | Implantable conductor coil formed from cabled composite wire | |
US5554176A (en) | Implantable electrode and sensor lead apparatus | |
US6925334B1 (en) | Implantable medical lead having multiple, jointly insulated electrical conductors | |
US9901731B2 (en) | Medical electrical lead having improved inductance | |
EP1935449B1 (en) | Braided electrical lead | |
US5897585A (en) | Stretchable pacing lead | |
US7065411B2 (en) | Electrical medical leads employing conductive aerogel | |
US8825181B2 (en) | Lead conductor with pitch and torque control for MRI conditionally safe use | |
US10039918B2 (en) | Implantable lead having a lumen with a wear-resistant liner | |
US20090299446A1 (en) | Durable fine wire lead for therapeutic electrostimulation and sensing | |
CN102802723A (en) | Medical Device Lead Including A Unifilar Coil With Improved Torque Transmission Capacity And Reduced Mri Heating | |
US20130041447A1 (en) | Durable fine wire lead for therapeutic electrostimulation and sensing | |
US20070282411A1 (en) | Compliant electrical stimulation leads and methods of fabrication | |
US20060200216A1 (en) | Fabrication of electrical medical leads employing multi-filar wire conductors | |
CN103143114A (en) | Detection/stimulation microprobe implantable in venous, arterial or lymphatic networks | |
US6580949B1 (en) | Implantable electrode lead | |
US5683444A (en) | Composite electrode | |
JP2011512200A (en) | Medical electrical lead with proximal protection | |
JP2015517383A (en) | Reinforced coil made from polymer-coated wire for improved torque transmission | |
US20140114384A1 (en) | Implantable fine wire lead for electrostimulation and sensing | |
US5330524A (en) | Defibrillation electrode with mesh configuration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |